[Aspects of the risks associated with vCJK from plasma derivatives from human plasma].
Burger
R
R
Offergeld
R
R
D000818:Animals; D016913:Blood Component Transfusion / Q000009:adverse effects; D003257:Consumer Product Safety; D007562:Creutzfeldt-Jakob Syndrome / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D018620:PrPSc Proteins / Q000032:analysis; D011634:Public Health; D018570:Risk Assessment / Q000379:methods; D012308:Risk Management / Q000379:methods; D065227:Transfusion Reaction
D018620:PrPSc Proteins